Debate Series - Estro-events.org

sCiEnTiFiC proGrAMME
Friday 11 May 2012
CliniCal inTERdiSCiPlinaRy PhySiCS RadiObiOlOgy RTT yOung
Page 114 PROgRammE & ExhibiTiOn guidE • ESTRO 31
abS. numbER
PROFFERED PAPERS
physiCs 5: iMAGinG For TrEATMEnT prEpArATion
And oUTCoME AssEssMEnT
08:45 - 10:00 • Room 117
ChaiR: R. Jeraj (USA)
CO-ChaiR: J. Marruecos Querol (Spain)
08:45 > Impact of tumor delineation errors on outcome prediction
based on DCE-MRI of cervical cancer patients receiving RT
E. Andersen (Norway), K.H. Hole, K.V. Lund, G.B. Kristensen,
H. Lyng, E. Malinen OC-0187
08:55 > GTV reduction on MRI during radiotherapy for oropharyngeal
cancer overestimates the reduction of the CTV
O. Hamming-Vrieze (The Netherlands), S.R. van Kranen,
C.A.H. Lange, M.W.M. van den Brekel, C.R.N. Rasch, J.J. Sonke OC-0188
09:05 > Temporal changes in DCE-MRI parameters during treatment
of locally advanced cervical cancer.
J.F. Kallehauge (Denmark), C. Nomden, C.S. Arteaga de Castro,
K. Tanderup, J.C. Lindegaard, R. Tersteeg, J. Roesink,
I.M. Jürgenliemk-Schulz, U. van der Heide OC-0189
09:15 > Visualizing treatment resistant regions within the tumor
using sequential DWI: clinical validation
H. Van Herck, M. Lambrecht (Belgium), V. Vandecaveye,
F. De Keyzer, P. Slagmolen, P. Suetens, R. Hermans, S. Nuyts OC-0190
09:25 > Parotid deformation during IMRT for head-neck cancer
correlates with clinical and dosimetry information
S. Broggi (Italy), C. Fiorino, E. Scalco, M.L. Belli, G. Sanguineti,
N. Dinapoli, V. Valentini, N. Di Muzio, G. Rizzo, G.M. Cattaneo OC-0191
09:35 > MRIgRT: characterization of the composite MR image
distortion field associated with organ motion
T. Stanescu (Canada), D.A. Jaffray OC-0192
09:45 > Auto-segmentation of bone in MRI-only based radiotherapy
using ultra short echo time
J.M. Edmund (Denmark), H.M. Kjer, R.H. Hansen OC-0193
Friday 11 May 2012
abS. numbER
SYMPOSIUM
dosE AssEssMEnT dUrinG TrEATMEnT:
TowArds GrEATEr ConTrol oF ThE dosE dEliVErEd To ThE pATiEnT
lEaRning ObJECTivES:
1. To understand the clinical importance of dose assessment during the treatment
2. To have an overview the state of art in methods to assess the dose delivered to the patient
3. To discuss the pros and cons of different approaches to reconstruct the delivered dose
08:45 - 10:00 • Room 116
ChaiR: N. Jornet (Spain)
CO-ChaiR: P. Galan Montenegro (Spain)
08:45 > Closing the loop of radiation therapy:
dose reconstruction using dynamic log files and CBCT
SPEaKER: L. Xing (USA) SP-0194
09:03 > Dose reconstruction using EPID and CBCT
SPEaKER: S. Nijsten (The Netherlands) SP-0195
09:21 > Dose reconstruction in tomotherapy
SPEaKER: R. Moeckli (Switzerland) SP-0196
09:39 > Implantable MOSFET dosimeters
SPEaKER: S. Beddar (USA) SP-0197
SYMPOSIUM
TUMoUr MiCroEnVironMEnT: noVEl bioloGy And noVEl TArGETs
lEaRning ObJECTivES:
1. To understand what effects oncogenic signalling inhibition can have on the tumor
microenvironment and radiation sensitivity
2. To understand the effects of hypoxia on signalling pathways and epigenetic regulation
of tumor cell behaviour
3. To understand how circulating bone marrow cells play a role in the radiosensitivity
of tumors
08:45 - 10:00 • Room 120-121
ChaiR: J. Kaanders (The Netherlands)
CO-ChaiR: R. Bristow (Canada)
08:45 > Altering the tumor microenvironment to improve radiation therapy
SPEaKER: R.J. Muschel (United Kingdom) SP-0198
ESTRO 31 • PROgRammE & ExhibiTiOn guidE Page 115
sCiEnTiFiC proGrAMME
eSTRO 31